The International Finance Facility for Immunisation (IFFIm) is a recently created multilateral development institution and registered as a charity with the Charity Commission for England and Wales. It is incorporated as a private company limited by guarantee under the UK Companies Act 1985. It has just raised US1 billion on the capital markets to assist with the funding of international immunisation programmes. It plans to raise more in the future. This is an exclusive interview with IFFIm's Chairman, Alan Gillespie, and one of the principal legal architects of the transaction structure, Jim Rice of Linklaters. Nb. Linklater's won Legal Business Magazine's award for “Banking and Finance Team of the Year” for it's work on the IFFFIm transaction.
Document Type: Research Article
Publication date: March 1, 2007
More about this publication?
Law and Financial Markets Review is a new, independent, English language journal devoted to providing high quality information, comment and analysis for lawyers specialising in banking and financial market issues and to others with interests in legal and regulatory developments affecting the financial markets. Published bi-monthly LFMR contains articles written by leading experts providing a forum for practical guidance on, as well as reflective and topical analysis of, all major jurisdictions, with a particular focus on the interaction between the law and market practice and behaviour.